Status:

COMPLETED

CASUS: Improved and Quality Assured Collection of First-void Urine

Lead Sponsor:

Universiteit Antwerpen

Collaborating Sponsors:

Amsterdam UMC, location VUmc

Novosanis NV

Conditions:

Cervical Cancer

Cervical Intraepithelial Neoplasia

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

The goal of the overall CASUS project is to develop the first fully molecular integrated cervical cancer screening approach, based on first-void urine as an easily accessible and non-invasive source o...

Detailed Description

CASUS work package 1 (WP1): To accommodate for the detection of biomarkers in first-void urine, a next-generation first-void urine collection device is necessary, which includes internal process contr...

Eligibility Criteria

Inclusion

  • Female
  • 18 years and older
  • Women with a high-risk HPV positive test result within six months prior to study enrolment.
  • Giving informed consent to the research team to contact his/her general practitioner and/or gynaecologist to access details of the participants HPV test results and cervical screening history.
  • Able to understand the information brochure/what the study is about.

Exclusion

  • Women that underwent hysterectomy or were treated for cervical (pre)cancer lesions within the previous six months prior to study enrolment.
  • Participating in another interventional clinical study (where e.g. a medical device, drug, or vaccine is evaluated) at the same time of participating in this study. Participation in another observational or low-interventional clinical study at the same time is allowed.

Key Trial Info

Start Date :

July 30 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 27 2019

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT04480866

Start Date

July 30 2019

End Date

November 27 2019

Last Update

July 21 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Centre for the Evaluation of Vaccination (CEV) - Vaccine & Infectious Disease Institute (VAXINFECTIO) - University of Antwerp

Wilrijk, Antwerpen, Belgium, 2610